lisaftoclax
ascentage pharmaceuticals
['hodgkin', 'lisaftoclax', 'apg-2575', 'lymphoma', 'ascent', 'ascentage', 'ascentage pharma']
dcbn news: eha 2022 | ascentage pharma releases encouraging results of bcl-2 inhibitor lisaftoclax (apg-2575) in chinese patients with relapsed/refractory non-hodgkin lymphoma: suzhou, china, and ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.